首页|靶向Rho激酶1纳米探针联合MRI可视化动脉粥样硬化斑块的实验研究

靶向Rho激酶1纳米探针联合MRI可视化动脉粥样硬化斑块的实验研究

扫码查看
目的 评估Rho激酶(Rho-kinase,ROCK)1在动脉粥样硬化(atherosclerosis,AS)斑块中的表达,合成ROCK1靶向探针,并探索其可视化AS斑块的可行性.材料与方法 ROCK1抗体与超小超顺磁性氧化铁纳米颗粒偶联制备靶向探针(Fe3O4@PEG-ROCK1)并表征.高脂喂养载脂蛋白E基因敲除(Apolipoprotein-Edeficient,ApoE-/-)小鼠,在10、16、22、28、34周随机取小鼠(n=5)测量体质量.主动脉免疫染色切片及蛋白印迹实验观察ROCK1的表达及活性.将34周ApoE-/-小鼠分成两组,一组尾静脉注射Fe3O4@PEG(n=10),一组尾静脉注射Fe3O4@PEG-ROCK1(n=10),注射探针前及注射后8、16 h进行MRI.Image J软件计算斑块信号.病理分析腹主动脉标本.结果 Fe3O4@PEG和Fe3O4@PEG-ROCK1在水溶液中均匀分散,水合粒径分别为(27.06±1.52)nm及(30.52±2.95)nm,Zeta电位分别为(-35.18±0.31)mV及(-16.60±3.26)mV.Fe3O4@PEG-ROCK1可降低巨噬细胞的吞噬清除,在一定浓度范围内无毒,且保持免疫活性.Fe3O4@PEG-ROCK1饱和磁化强度为0.0868 T及T2弛豫率为162.3 mM-1s-1说明探针磁敏感性较好.随着AS进展,ApoE-/-鼠体质量明显增加,ROCK1在斑块中的表达逐渐增多(r=0.959,P<0.001).ApoE-/-鼠腹主动脉ROCK1活性高于健康C57BL/6鼠(0.30±0.02 vs.0.24±0.02,P<0.001).平扫时Fe3O4@PEG和Fe3O4@PEG-ROCK1组斑块信号分别为8.25±1.39和7.81±3.22,差异无统计学意义;注射探针后两组斑块信号均减低,与Fe3O4@PEG组相比,Fe3O4@PEG-ROCK1组的斑块信号减低更明显(8 h,5.37±1.79 vs.3.91±2.26,P= 0.001;16 h,6.68±2.39 vs.4.61±2.80,P=0.001).普鲁士蓝染色显示的铁纳米沉积区域与免疫组化的ROCK1阳性区域对应.结论 ROCK1在AS斑块中表达高和活性高.ROCK1靶向探针(Fe3O4@PEG-ROCK1)是有效磁共振对比剂,有助于实现风险斑块的无创监测.
Experimental MRI study of targeting Rho-associated protein kinase 1 to detect plaques in atherosclerosis
Objective:To observe the expression of Rho-kinase(ROCK)1 in atherosclerotic plaques,to synthesize a ROCK1-targeted probe and characterize it,then explore its ability to visualize atherosclerotic plaques.Materials and Methods:The ROCK1 antibody was coupled with ultra-small superparamagnetic iron oxide nanoparticles to prepare the targeting probe(Fe3O4@PEG-ROCK1),which was characterized and analyzed.Apolipoprotein E knockout(ApoE-/-)mice were fed with high-fat diet and five mice were selected randomly at 10,16,22,28,and 34 weeks,respectively,to measure weight.The expression and activity of ROCK1 were observed by ROCK1 immunostaining and western blot.ApoE-/-mice fed for 34 weeks were divided into two groups,one group(n=10)was injected with Fe3O4@PEG,the other group(n=10)was injected with Fe3O4@PEG-ROCK1.Magnetic resonance imaging was performed before and 8 h and 16 h after injection of the nanoprobe,and the signal intensity of plaques was calculated by Image J software.Abdominal aortic specimens were analyzed by pathology.Results:Fe3O4@PEG and Fe3O4@PEG-ROCK1 were uniformly dispersed in aqueous solution,and the hydrated particle sizes were(27.06±1.52)nm and(30.52±2.95)nm,respectively.The Zeta potential was(-35.18±0.31)mV and(-16.60±3.26)mV,respectively.Fe3O4@PEG-ROCK1 could reduce the phagocytosis and clearance of macrophages,was non-toxic within a certain concentration range,and maintains immune activity.The saturation magnetization(0.0868 T)and T2 relaxation rate(162.3 mM-1s-1)indicated that Fe3O4@PEG-ROCK1 had good magnetic sensitivity.With advancing atherosclerosis,the expression of ROCK1 increased(r=0.959,P<0.001).The activity of ROCK1 in abdominal aorta of ApoE-/-mice was higher than that of C57BL/6 mice(0.30±0.02 vs.0.24±0.02,P<0.01).The results of magnetic resonance imaging showed that compared with plain scan(the plaque signal of Fe3O4@PEG group and Fe3O4@PEG-ROCK1 group were 8.25±1.39 and 7.81±3.22,respectively).After the injection of the probe,the plaque signal of the two groups decreased.Compared with the Fe3O4@PEG group,the plaque signal of the target probe Fe3O4@PEG-ROCK1 group decreased more significantly(8 h,5.37±1.79 vs.3.91±2.26,P=0.001;16 h,6.68±2.39 vs.4.61±2.80,P=0.001).Prussian blue staining revealed the deposition of nanoprobes within the plaques,corresponding to the positive areas of immunohistochemistry.Conclusions:ROCK1 is highly expressed and active in atherosclerotic plaques.Fe3O4@PEG-ROCK1 may be used as an effective magnetic resonance contrast-enhancing agent for the non-invasive detection of atherosclerotic plaques to promote the visual detection of plaques.

mouseatherosclerosisRho-kinasenanoprobemolecular imagingmagnetic resonance imaging

杨雅雯、夏敏、宋梦星、马占龙

展开 >

南京医科大学第一附属医院(江苏省人民医院)放射科,南京 210029

小鼠 动脉粥样硬化 Rho激酶 纳米探针 分子影像 磁共振成像

国家自然科学基金项目

81971669

2024

磁共振成像
中国医院协会 首都医科大学附属北京天坛医院

磁共振成像

CSTPCD北大核心
影响因子:1.38
ISSN:1674-8034
年,卷(期):2024.15(4)
  • 35